Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies—medications that lower blood sugar and reduce the risk of heart disease in people with diabetes—affect the risk of developing dementia.
GLP-1 receptor agonist diabetes medications linked to reduced dementia risk
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
